Vivos Therapeutics, Inc. (VVOS)

0.262 -0.01 (-5.35%) USD  |  NASDAQ  |  Aug 25, 16:00
0.273 +0.01 (+4.20%) After-Hours: 19:16
More

Vivos Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for VVOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 19, 2026 --
July 08, 2026 --
June 04, 2026 --
May 27, 2026 --
April 20, 2026 --
April 17, 2026 --
February 11, 2026 --
December 03, 2025 --
December 02, 2025 --
November 17, 2025 --
November 14, 2025 --
September 09, 2025 --
August 21, 2025 --
May 20, 2025 --
April 15, 2025 --
Date Value
April 01, 2025 --
November 19, 2024 --
August 20, 2024 --
August 19, 2024 --
May 20, 2024 --
April 08, 2024 --
February 23, 2024 --
November 17, 2023 --
November 13, 2023 --
August 30, 2023 --
August 17, 2023 --
June 15, 2023 --
June 09, 2023 --
April 08, 2023 --
April 03, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Hinge Health, Inc. Upgrade
Exlites Holdings International, Inc. --
Xcelerate, Inc. --
Haemonetics Corp. Upgrade
Pro-Dex, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade